| Year |
Citation |
Score |
| 2020 |
Schulte JJ, Steinmetz J, Furtado LV, Husain AN, Lingen MW, Cipriani NA. Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful? Head and Neck Pathology. PMID 32350806 DOI: 10.1007/S12105-020-01165-9 |
0.339 |
|
| 2020 |
Limbach AL, Lingen MW, McElherne J, Mashek H, Fitzpatrick C, Hyjek E, Mostofi R, Cipriani NA. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma. Head and Neck Pathology. PMID 32026294 DOI: 10.1007/S12105-020-01139-X |
0.34 |
|
| 2020 |
Polverini PJ, Lingen MW. A History of Innovations in the Diagnosis and Treatment of Oral and Head and Neck Cancer. Journal of Dental Research. 98: 489-497. PMID 31008698 DOI: 10.1177/0022034519833645 |
0.343 |
|
| 2020 |
Izumchenko E, Hasina R, Hariharan AK, Shanmugam A, Irusappan S, Maji S, Bahadur U, Veeramachaneni V, Bettadapura R, Ravichandran A, Hariharan R, Gupta V, Rao VUS, Bagadia RK, N.M.L M, ... Lingen MW, et al. Detection of somatic mutations in saliva of patients with oral cavity squamous cell carcinoma. Journal of Clinical Oncology. 38: 6562-6562. DOI: 10.1200/Jco.2020.38.15_Suppl.6562 |
0.36 |
|
| 2019 |
Schubert AD, Channah Broner E, Agrawal N, London N, Pearson A, Gupta A, Wali N, Seiwert TY, Wheelan S, Lingen M, Macleod K, Allen H, Chatterjee A, Vassiliki S, Gaykalova D, et al. Somatic mitochondrial mutation discovery using ultra-deep sequencing of the mitochondrial genome reveals spatial tumor heterogeneity in head and neck squamous cell carcinoma. Cancer Letters. PMID 31830557 DOI: 10.1016/J.Canlet.2019.12.006 |
0.342 |
|
| 2019 |
Saloura V, Izumchenko E, Zuo Z, Bao R, Korzinkin M, Ozerov I, Zhavoronkov A, Sidransky D, Bedi A, Hoque MO, Koeppen H, Keck MK, Khattri A, London N, Kotlov N, ... ... Lingen M, et al. Immune profiles in primary squamous cell carcinoma of the head and neck. Oral Oncology. 96: 77-88. PMID 31422218 DOI: 10.1016/J.Oraloncology.2019.06.032 |
0.374 |
|
| 2019 |
Cipriani NA, Lusardi JJ, McElherne J, Pearson AT, Olivas AD, Fitzpatrick C, Lingen MW, Blair EA. Mucoepidermoid Carcinoma: A Comparison of Histologic Grading Systems and Relationship to MAML2 Rearrangement and Prognosis. The American Journal of Surgical Pathology. PMID 31021855 DOI: 10.1097/Pas.0000000000001252 |
0.315 |
|
| 2018 |
Seiwert TY, Foster CC, Blair EA, Karrison TG, Agrawal N, Melotek JM, Portugal L, Brisson RJ, Dekker A, Kochanny S, Gooi Z, Lingen MW, Villaflor VM, Ginat DT, Haraf DJ, et al. OPTIMA: A Phase II Dose and Volume De-Escalation Trial for Human Papillomavirus-Positive Oropharyngeal Cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30481287 DOI: 10.1093/Annonc/Mdy522 |
0.311 |
|
| 2018 |
Lee SS, Bindokas VP, Lingen MW, Kron SJ. Nondestructive, multiplex three-dimensional mapping of immune infiltrates in core needle biopsy. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 30401959 DOI: 10.1038/S41374-018-0156-Y |
0.339 |
|
| 2018 |
Fakhry C, Lacchetti C, Rooper LM, Jordan RC, Rischin D, Sturgis EM, Bell D, Lingen MW, Harichand-Herdt S, Thibo J, Zevallos J, Perez-Ordonez B. Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800684. PMID 30188786 DOI: 10.1200/Jco.18.00684 |
0.365 |
|
| 2018 |
Nikitakis NG, Pentenero M, Georgaki M, Poh CF, Peterson DE, Edwards P, Lingen M, Sauk JJ. Molecular markers associated with development and progression of potentially premalignant oral epithelial lesions: Current knowledge and future implications. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. PMID 29709496 DOI: 10.1016/J.Oooo.2018.03.012 |
0.359 |
|
| 2018 |
Saintigny P, William WN, Foy JP, Papadimitrakopoulou V, Lang W, Zhang L, Fan YH, Feng L, Kim ES, El-Naggar AK, Lee JJ, Mao L, Hong WK, Lingen MW, Lippman SM. Met Receptor Tyrosine Kinase and Chemoprevention of Oral Cancer. Journal of the National Cancer Institute. 110. PMID 29617836 DOI: 10.1093/Jnci/Djx186 |
0.358 |
|
| 2018 |
Drazer MW, Kadri S, Sukhanova M, Patil SA, West AH, Feurstein S, Calderon DA, Jones MF, Weipert CM, Daugherty CK, Ceballos-López AA, Raca G, Lingen MW, Li Z, Segal JP, et al. Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Advances. 2: 146-150. PMID 29365323 DOI: 10.1182/Bloodadvances.2017013037 |
0.322 |
|
| 2018 |
Khattri A, Sheikh N, Acharya R, Tan YC, Kochanny S, Lingen MW, Vokes EE, Seiwert TY. Mechanism of acquired resistance to cetuximab in head and neck cancer. Journal of Clinical Oncology. 36: e18061-e18061. DOI: 10.1200/Jco.2018.36.15_Suppl.E18061 |
0.337 |
|
| 2017 |
Can NT, Lingen MW, Mashek H, McElherne J, Briese R, Fitzpatrick C, van Zante A, Cipriani NA. Expression of Hormone Receptors and HER-2 in Benign and Malignant Salivary Gland Tumors. Head and Neck Pathology. PMID 28681314 DOI: 10.1007/S12105-017-0833-Y |
0.334 |
|
| 2017 |
Saloura V, Fatima A, Zewde M, Kiyotani K, Brisson RJ, Park JH, Ikeda Y, Vougiouklakis T, Bao R, Seiwert TY, Cipriani NA, Lingen MW, Vokes EE, Nakamura Y. Characterization of the tumor T-cell receptor repertoire and immune microenvironment in patients with locoregionally advanced squamous cell carcinoma of the head and neck. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28442504 DOI: 10.1158/1078-0432.CCR-17-0103 |
0.397 |
|
| 2017 |
Saloura V, Vougiouklakis T, Zewde M, Deng X, Kiyotani K, Park JH, Matsuo Y, Lingen M, Suzuki T, Dohmae N, Hamamoto R, Nakamura Y. WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer. Scientific Reports. 7: 40664. PMID 28102297 DOI: 10.1038/Srep40664 |
0.329 |
|
| 2017 |
Khattri A, Zuo Z, Tan YC, Agrawal N, Lingen MW, Vokes EE, Seiwert TY. Association of DRB1 and DRBQ haplotype 04:01~03:01 with HPV positive head and neck squamous cell carcinoma. Journal of Clinical Oncology. 35: 6054-6054. DOI: 10.1200/Jco.2017.35.15_Suppl.6054 |
0.306 |
|
| 2017 |
Seiwert TY, Bao R, Tan YC, Acharya R, Brisson RJ, Kochanny S, Arshad S, Zuo Z, Saloura V, Agrawal N, Gooi Z, Blair EA, Lingen MW, Vokes EE, Gajewski T, et al. Correlation of constitutive PD-1 resistance in HNC with GM-CSF expression and presence of myeloid derived suppressor cells (MDSCs). Journal of Clinical Oncology. 35: 6049-6049. DOI: 10.1200/Jco.2017.35.15_Suppl.6049 |
0.357 |
|
| 2017 |
Saloura V, Vougiouklakis T, Zewde M, Deng X, Kiyotani K, Park J, Matsuo Y, Lingen M, Dohmae N, Suzuki T, Hamamoto R, Nakamura Y. Abstract 342: WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer Cancer Research. 77: 342-342. DOI: 10.1158/1538-7445.Am2017-342 |
0.332 |
|
| 2017 |
Levin M, Lingen M, Schwartz D, Snyder H. Abstract 2684: Multiplex immunofluorescence profiling of tumor infiltrating immune subsets in HNSCC biopsies provides a powerful tool when combined with patient outcome data Cancer Research. 77: 2684-2684. DOI: 10.1158/1538-7445.Am2017-2684 |
0.39 |
|
| 2016 |
Melotek JM, Villaflor VM, Seiwert TY, Kocherginsky M, Karrison TG, Brisson RJ, Blair EA, Stenson KM, Lingen M, Cohen E, Vokes EE, Haraf DJ. Pooled Analysis of Late Toxicity From 2 Randomized Phase 2 Trials of Induction Chemotherapy (IC) and Chemoradiation Therapy (CRT) for Locally Advanced Head and Neck Squamous Cell Cancer (LA-HNSCC). International Journal of Radiation Oncology, Biology, Physics. 96: E351-E352. PMID 27674454 DOI: 10.1016/J.Ijrobp.2016.06.1513 |
0.311 |
|
| 2016 |
Seiwert TY, Melotek JM, Blair EA, Stenson KM, Salama JK, Witt ME, Brisson RJ, Chawla A, Dekker A, Lingen MW, Kocherginsky M, Villaflor VM, Cohen EE, Haraf DJ, Vokes EE. Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer. International Journal of Radiation Oncology, Biology, Physics. 96: 21-9. PMID 27511844 DOI: 10.1016/J.Ijrobp.2016.04.030 |
0.331 |
|
| 2016 |
Saloura V, Vougiouklakis T, Zewde M, Kiyotani K, Park JH, Gao G, Karrison T, Lingen M, Nakamura Y, Hamamoto R. WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck. Oncotarget. PMID 27285764 DOI: 10.18632/Oncotarget.9897 |
0.387 |
|
| 2016 |
Rolle CE, Tan YC, Seiwert TY, Vora S, Kanteti R, Hasina R, Carey GB, Surati M, Weichselbaum RR, Lingen MW, Vokes EE, Salgia R. Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma. Oncotarget. PMID 27244893 DOI: 10.18632/Oncotarget.9640 |
0.383 |
|
| 2016 |
Khammanivong A, Sorenson BS, Ross KF, Dickerson EB, Hasina R, Lingen MW, Herzberg MC. Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC. Oncotarget. PMID 26883112 DOI: 10.18632/Oncotarget.7373 |
0.347 |
|
| 2016 |
Levin M, Lingen M, Schwartz D, Snyder H. Abstract A109: Immune profiling of tumor infiltrating lymphocyte subsets, myeloid cells and HPV status of HNSCC biopsies using multiplex immunofluorescence Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-A109 |
0.403 |
|
| 2015 |
William WN, Papadimitrakopoulou V, Lee JJ, Mao L, Cohen EE, Lin HY, Gillenwater AM, Martin JW, Lingen MW, Boyle JO, Shin DM, Vigneswaran N, Shinn N, Heymach JV, Wistuba II, et al. Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial. Jama Oncology. 1-8. PMID 26540028 DOI: 10.1001/Jamaoncol.2015.4364 |
0.314 |
|
| 2015 |
Xiao H, Langerman A, Zhang Y, Khalid O, Hu S, Cao CX, Lingen MW, Wong DT. Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery. Oral Oncology. PMID 26321370 DOI: 10.1016/J.Oraloncology.2015.08.008 |
0.341 |
|
| 2015 |
Zhong R, Bao R, Faber PW, Bindokas VP, Bechill J, Lingen MW, Spiotto MT. Notch1 Activation or Loss Promotes HPV-Induced Oral Tumorigenesis. Cancer Research. 75: 3958-69. PMID 26294213 DOI: 10.1158/0008-5472.Can-15-0199 |
0.441 |
|
| 2015 |
Macey R, Walsh T, Brocklehurst P, Kerr AR, Liu JL, Lingen MW, Ogden GR, Warnakulasuriya S, Scully C. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. The Cochrane Database of Systematic Reviews. 5: CD010276. PMID 26021841 DOI: 10.1002/14651858.Cd010276.Pub2 |
0.316 |
|
| 2015 |
Brand TM, Iida M, Stein AP, Corrigan KL, Braverman CM, Coan JP, Pearson HE, Bahrar H, Fowler TL, Bednarz BP, Saha S, Yang D, Gill PS, Lingen MW, Saloura V, et al. AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 2601-12. PMID 25767293 DOI: 10.1158/1078-0432.Ccr-14-2648 |
0.338 |
|
| 2015 |
Schechter RB, Nagilla M, Joseph L, Reddy P, Khattri A, Watson S, Locati LD, Licitra L, Greco A, Pelosi G, Carcangiu ML, Lingen MW, Seiwert TY, Cohen EE. Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy. Cancer Letters. 359: 269-74. PMID 25641339 DOI: 10.1016/J.Canlet.2015.01.024 |
0.376 |
|
| 2015 |
Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Brägelmann J, DeBoer R, El-Dinali M, Aktolga S, Lei Z, Tan P, ... ... Lingen MW, et al. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 870-81. PMID 25492084 DOI: 10.1158/1078-0432.Ccr-14-2481 |
0.333 |
|
| 2015 |
Saloura V, Cho HS, Kiyotani K, Alachkar H, Zuo Z, Nakakido M, Tsunoda T, Seiwert T, Lingen M, Licht J, Nakamura Y, Hamamoto R. WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck. Molecular Cancer Research : McR. 13: 293-304. PMID 25280969 DOI: 10.1158/1541-7786.Mcr-14-0292-T |
0.439 |
|
| 2015 |
Khattri A, Zuo Z, Brägelmann J, Keck MK, El Dinali M, Brown CD, Stricker T, Munagala A, Cohen EE, Lingen MW, White KP, Vokes EE, Seiwert TY. Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma. Oral Oncology. 51: 53-8. PMID 25255959 DOI: 10.1016/J.Oraloncology.2014.08.014 |
0.347 |
|
| 2015 |
Seiwert TY, Zuo Z, Keck MK, Khattri A, Pedamallu CS, Stricker T, Brown C, Pugh TJ, Stojanov P, Cho J, Lawrence MS, Getz G, Brägelmann J, DeBoer R, Weichselbaum RR, ... ... Lingen MW, et al. Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 632-41. PMID 25056374 DOI: 10.1158/1078-0432.Ccr-13-3310 |
0.333 |
|
| 2015 |
Bragelmann J, Zuo Z, Khattri A, Keck MK, Villaflor VM, DeSouza J, Haraf DJ, Lingen MW, Vokes EE, Seiwert TY. Comparison of two large, genetically and clinically annotated head and neck cancer (HNC) cohorts (TCGA, CHGC) and differential treatment effects on TP53 mutated, as well as oral cavity cancers. Journal of Clinical Oncology. 33: 6080-6080. DOI: 10.1200/Jco.2015.33.15_Suppl.6080 |
0.315 |
|
| 2015 |
Zuo Z, Saloura V, Kohrt HE, Keck MK, Khattri A, Lingen MW, Kline JP, Gajewski T, Vokes EE, Seiwert TY. Correlation of specific genetic aberrations and signaling pathways with T-cell inflamed phenotype (TCIP) in head and neck cancer and as novel candidate biomarkers for checkpoint blockade therapy. Journal of Clinical Oncology. 33: 6079-6079. DOI: 10.1200/Jco.2015.33.15_Suppl.6079 |
0.359 |
|
| 2015 |
Saloura V, Zuo Z, Khattri A, Kohrt HE, Lingen MW, Gajewski T, Kowanetz M, Vokes EE, Seiwert TY. Patterns of CD8+ T-cell infiltration and immune escape mechanisms in head and neck cancer. Journal of Clinical Oncology. 33: 6078-6078. DOI: 10.1200/Jco.2015.33.15_Suppl.6078 |
0.316 |
|
| 2015 |
Rajasekaran N, Kohrt HE, Zuo Z, Keck MK, Khattri A, Lingen MW, Kline JP, Gajewski T, Vokes EE, Seiwert TY. Exploratory analysis of clinical and translational factors associated with the inflamed phenotype in HNSCC. Journal of Clinical Oncology. 33: 3031-3031. DOI: 10.1200/Jco.2015.33.15_Suppl.3031 |
0.35 |
|
| 2015 |
Mowers EE, Lingen M, Cohen EEW, Macleod K. Abstract 3615: Autophagy as a drug target to prevent tumor progression in head and neck squamous cell carcinoma: Validation using a physiologically relevant mouse model Cancer Research. 75: 3615-3615. DOI: 10.1158/1538-7445.Am2015-3615 |
0.432 |
|
| 2015 |
Saloura V, Vougiouklakis T, Lingen M, Seiwert T, Vokes E, Nakamura Y, Hamamoto R. Abstract 101: WHSC1L1 as a therapeutic target in squamous cell carcinoma of the head and neck Cancer Research. 75: 101-101. DOI: 10.1158/1538-7445.Am2015-101 |
0.44 |
|
| 2015 |
Spiotto M, Zhong R, Bao R, Faber P, Bechill J, Lingen M. Insertional Mutagenesis in HPV Cancers Identifies That Paradoxical Notch1 Activity Promotes Tumorigenesis International Journal of Radiation Oncology*Biology*Physics. 93: S72-S73. DOI: 10.1016/J.Ijrobp.2015.07.174 |
0.327 |
|
| 2014 |
Ferguson BD, Tretiakova MS, Lingen MW, Gill PS, Salgia R. Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition. Growth Factors (Chur, Switzerland). 32: 202-6. PMID 25391996 DOI: 10.3109/08977194.2014.980904 |
0.414 |
|
| 2014 |
Seiwert TY, Wang X, Heitmann J, Villegas-Bergazzi V, Sprott K, Finn S, O'Regan E, Farrow AD, Weichselbaum RR, Lingen MW, Cohen EE, Stenson K, Weaver DT, Vokes EE. DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer. Plos One. 9: e102112. PMID 25019640 DOI: 10.1371/Journal.Pone.0102112 |
0.315 |
|
| 2014 |
Farah CS, Woo SB, Zain RB, Sklavounou A, McCullough MJ, Lingen M. Oral cancer and oral potentially malignant disorders. International Journal of Dentistry. 2014: 853479. PMID 24891850 DOI: 10.1155/2014/853479 |
0.311 |
|
| 2014 |
Kuo WL, Sharifi MN, Lingen MW, Ahmed O, Liu J, Nagilla M, Macleod KF, Cohen EE. p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors. Plos One. 9: e90171. PMID 24599075 DOI: 10.1371/Journal.Pone.0090171 |
0.368 |
|
| 2014 |
Lauxen IS, Oliveira MG, Rados PV, Lingen MW, Nör JE, Sant'Ana Filho M. Immunoprofiling of oral squamous cell carcinomas reveals high p63 and survivin expression Oral Diseases. 20. PMID 23738964 DOI: 10.1111/Odi.12136 |
0.41 |
|
| 2014 |
Heitmann J, Zuo Z, Geeleher P, Keck MK, Khattri A, Lingen MW, DeSouza J, Villaflor VM, Beckett M, Weichselbaum RR, Vokes EE, Seiwert TY. Correlation of homologous recombination deficiency in head and neck cancer with sensitivity to PARP inhibition. Journal of Clinical Oncology. 32: 6094-6094. DOI: 10.1200/Jco.2014.32.15_Suppl.6094 |
0.323 |
|
| 2014 |
Rieke D, Zuo Z, Chawla A, Keck MK, Endhardt K, Fang P, Khattri A, Braegelmann J, Lingen MW, Vokes EE, Seiwert TY. Effect of FGFR1 on epithelial-mesenchymal transition and EGFR resistance in HNC: A systems biology approach. Journal of Clinical Oncology. 32: 6091-6091. DOI: 10.1200/Jco.2014.32.15_Suppl.6091 |
0.419 |
|
| 2014 |
Saloura V, Zuo Z, Koeppen H, Keck MK, Khattri A, Boe M, Hegde PS, Xiao Y, Nakamura Y, Vokes EE, De Souza JA, Villaflor VM, Kline JP, Gajewski T, Lingen MW, et al. Correlation of T-cell inflamed phenotype with mesenchymal subtype, expression of PD-L1, and other immune checkpoints in head and neck cancer. Journal of Clinical Oncology. 32: 6009-6009. DOI: 10.1200/Jco.2014.32.15_Suppl.6009 |
0.37 |
|
| 2014 |
Saloura V, Nakakido M, Alachkar H, Seiwert T, Lingen M, Cohen E, Nakamura Y, Hamamoto R. Abstract 5153: Wolf-Hirschhorn syndrome candidate 1 as a potential novel therapeutic target for head and neck cancer Cancer Research. 74: 5153-5153. DOI: 10.1158/1538-7445.Am2014-5153 |
0.424 |
|
| 2014 |
Koutlas I, Lingen M, Binder S, Gopalakrishnan R, Argyris P, Li X, Wright J. Are atypical juvenile gingival epithelial hyperplasias (juvenile gingival keratoacanthomas) really squamous cell carcinomas and vice versa? Contradictory clinical and molecular findings Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 118: e184-e185. DOI: 10.1016/J.Oooo.2014.05.063 |
0.314 |
|
| 2014 |
ABRAHAO AC, CASTILHO RM, MOLINOLO A, LINGEN M, GUTKIND JS, SQUARIZE CH. PTEN Downregulation Leads to Augmented Angiogenesis and Increased COX-2 Expression in HNSCC Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 117: e220-e221. DOI: 10.1016/J.Oooo.2013.12.363 |
0.335 |
|
| 2013 |
Walsh T, Liu JL, Brocklehurst P, Glenny AM, Lingen M, Kerr AR, Ogden G, Warnakulasuriya S, Scully C. Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. The Cochrane Database of Systematic Reviews. 11: CD010173. PMID 24258195 DOI: 10.1002/14651858.Cd010173.Pub2 |
0.302 |
|
| 2013 |
Zhao L, Antic T, Witten D, Paner GP, Taxy JB, Husain A, Gwin K, Mirza MK, Lingen MW, Tretiakova MS. Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas. The American Journal of Surgical Pathology. 37: 1876-81. PMID 24121175 DOI: 10.1097/Pas.0B013E31829E2525 |
0.409 |
|
| 2013 |
Squarize CH, Castilho RM, Abrahao AC, Molinolo A, Lingen MW, Gutkind JS. PTEN deficiency contributes to the development and progression of head and neck cancer. Neoplasia (New York, N.Y.). 15: 461-71. PMID 23633918 DOI: 10.1593/Neo.121024 |
0.439 |
|
| 2013 |
Liang H, Deng L, Chmura S, Burnette B, Liadis N, Darga T, Beckett MA, Lingen MW, Witt M, Weichselbaum RR, Fu YX. Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing. Journal of Immunology (Baltimore, Md. : 1950). 190: 5874-81. PMID 23630355 DOI: 10.4049/Jimmunol.1202612 |
0.345 |
|
| 2013 |
Brägelmann J, Dagogo-Jack I, El Dinali M, Stricker T, Brown CD, Zuo Z, Khattri A, Keck M, McNerney ME, Longnecker R, Bieging K, Kocherginsky M, Alexander K, Salgia R, Lingen MW, et al. Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA. Oral Oncology. 49: 525-33. PMID 23490885 DOI: 10.1016/J.Oraloncology.2013.02.003 |
0.4 |
|
| 2013 |
Seiwert TY, Darga T, Haraf D, Blair EA, Stenson K, Cohen EE, Salama JK, Villaflor V, Witt ME, Lingen MW, Weichselbaum RR, Vokes EE. A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFeradeâ„¢ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 769-76. PMID 23104721 DOI: 10.1093/Annonc/Mds523 |
0.303 |
|
| 2013 |
Hasina R, Mollberg N, Kawada I, Mutreja K, Kanade G, Yala S, Surati M, Liu R, Li X, Zhou Y, Ferguson BD, Nallasura V, Cohen KS, Hyjek E, Mueller J, ... ... Lingen MW, et al. Critical role for the receptor tyrosine kinase EPHB4 in esophageal cancers. Cancer Research. 73: 184-94. PMID 23100466 DOI: 10.1158/0008-5472.Can-12-0915 |
0.448 |
|
| 2013 |
Doçi CL, Zhou G, Lingen MW. The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression. Oncogene. 32: 4377-86. PMID 23085760 DOI: 10.1038/Onc.2012.464 |
0.745 |
|
| 2013 |
Lingen MW, Xiao W, Schmitt A, Jiang B, Pickard R, Kreinbrink P, Perez-Ordonez B, Jordan RC, Gillison ML. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncology. 49: 1-8. PMID 22841678 DOI: 10.1016/J.Oraloncology.2012.07.002 |
0.327 |
|
| 2013 |
Keck MK, Zuo Z, Khattri A, Brown CD, Stricker T, Weichselbaum RR, Lingen MW, Cohen EE, White KP, Vokes EE, Hammerman PS, Seiwert TY. Genomic profiling of kinase genes in head and neck squamous cell carcinomas to identify potentially targetable genetic aberrations in FGFR1/2, DDR2, EPHA2, and PIK3CA. Journal of Clinical Oncology. 31: 6010-6010. DOI: 10.1200/Jco.2013.31.15_Suppl.6010 |
0.384 |
|
| 2013 |
Saintigny P, Lingen MW, William WN, Lang W, Feng L, Lee JJ, Kim ES, El-Naggar AK, Papadimitrakopoulou V, Lippman SM, Mao L, Hong WK. Abstract LB-186: MET receptor tyrosine kinase is a potential novel target for prevention of oral cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Am2013-Lb-186 |
0.4 |
|
| 2013 |
Saloura V, Cho H, Lingen M, Li T, Gong C, Tanguy S, Cohen E, Hamamoto R, Nakamura Y. Abstract 2979: Wolf-Hirschhorn syndrome candidate 1 plays an important role in the pathogenesis of head and neck cancer. Cancer Research. 73: 2979-2979. DOI: 10.1158/1538-7445.Am2013-2979 |
0.433 |
|
| 2012 |
Mankame TP, Lingen MW. The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7. Neoplasia (New York, N.Y.). 14: 1213-22. PMID 23308053 DOI: 10.1593/Neo.121422 |
0.777 |
|
| 2012 |
Jordan RC, Lingen MW, Perez-Ordonez B, He X, Pickard R, Koluder M, Jiang B, Wakely P, Xiao W, Gillison ML. Validation of methods for oropharyngeal cancer HPV status determination in US cooperative group trials. The American Journal of Surgical Pathology. 36: 945-54. PMID 22743284 DOI: 10.1097/Pas.0B013E318253A2D1 |
0.322 |
|
| 2012 |
Wu X, Chen P, Sonis ST, Lingen MW, Berger A, Toback FG. A novel Peptide to treat oral mucositis blocks endothelial and epithelial cell apoptosis. International Journal of Radiation Oncology, Biology, Physics. 83: e409-15. PMID 22420966 DOI: 10.1016/J.Ijrobp.2012.01.006 |
0.315 |
|
| 2012 |
de Souza JA, Davis DW, Zhang Y, Khattri A, Seiwert TY, Aktolga S, Wong SJ, Kozloff MF, Nattam S, Lingen MW, Kunnavakkam R, Stenson KM, Blair EA, Bozeman J, Dancey JE, et al. A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2336-43. PMID 22371453 DOI: 10.1158/1078-0432.Ccr-11-2825 |
0.316 |
|
| 2012 |
Bainer RO, Veneris JT, Yamada SD, Montag A, Lingen MW, Gilad Y, Rinker-Schaeffer CW. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization. Clinical & Experimental Metastasis. 29: 397-408. PMID 22350525 DOI: 10.1007/S10585-011-9448-Y |
0.402 |
|
| 2012 |
Elashoff D, Zhou H, Reiss J, Wang J, Xiao H, Henson B, Hu S, Arellano M, Sinha U, Le A, Messadi D, Wang M, Nabili V, Lingen M, Morris D, et al. Prevalidation of salivary biomarkers for oral cancer detection. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 664-72. PMID 22301830 DOI: 10.1158/1055-9965.Epi-11-1093 |
0.347 |
|
| 2012 |
Doçi CL, Mankame TP, Langerman A, Ostler KR, Kanteti R, Best T, Onel K, Godley LA, Salgia R, Lingen MW. Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 31: 15-24. PMID 22123719 DOI: 10.1097/Pgp.0B013E318220Ba16 |
0.753 |
|
| 2012 |
Seiwert TY, Keck MK, Zuo Z, Khattri A, Brown C, Stricker T, Rieke D, Lingen MW, Cohen EEW, White KP, Vokes EE. Genomic profiling of a clinically annotated cohort of locoregionally advanced head and neck cancers (HNC) treated with definitive chemoradiotherapy. Journal of Clinical Oncology. 30: 5517-5517. DOI: 10.1200/Jco.2012.30.15_Suppl.5517 |
0.398 |
|
| 2012 |
Keck MK, Zuo Z, Khattri A, Braegelmann J, Lingen M, Rieke D, Geiss G, Gerlach J, Vokes E, Seiwert TY. Abstract LB-398: Detection of copy number alterations in 124 head and neck squamous cell carcinomas using the Nanostring nCounter assay Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-398 |
0.399 |
|
| 2012 |
Hasina R, Mutreja K, Kawada I, Kanteti R, Arif Q, Liu R, Li X, Zhou Y, Hyjek E, Lingen MW, Mueller J, Waxman I, Villaflor V, Ferguson M, Vokes EE, et al. Abstract 1861: EPHB4 as a potential therapeutic target for esophageal cancer Cancer Research. 72: 1861-1861. DOI: 10.1158/1538-7445.Am2012-1861 |
0.407 |
|
| 2011 |
Gillison ML, Jordan R, Lingen M, Perez-Ordonez B, He X, Pickard R, Inman A, Koluder M, Jiang B, Wakely P, Xiao W. Predictive value of human papillomavirus (HPV) 16 in situ hybridization (ISH) and p16 immunohistochemistry (IHC) for HPV oncogene expression in paraffin-embedded oropharynx squamous cell carcinoma (OPSCC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5512. PMID 28021424 DOI: 10.1200/Jco.2011.29.15_Suppl.5512 |
0.308 |
|
| 2011 |
Lingen MW. Brush-based cytology screening in the tonsils and cervix: there is a difference! Cancer Prevention Research (Philadelphia, Pa.). 4: 1350-2. PMID 21893496 DOI: 10.1158/1940-6207.Capr-11-0373 |
0.312 |
|
| 2011 |
Chen P, Lingen M, Sonis ST, Walsh-Reitz MM, Toback FG. Role of AMP-18 in Oral Mucositis Oral Oncology. 47: 831-839. PMID 21737340 DOI: 10.1016/J.Oraloncology.2011.06.012 |
0.337 |
|
| 2011 |
Glubb DM, Cerri E, Giese A, Zhang W, Mirza O, Thompson EE, Chen P, Das S, Jassem J, Rzyman W, Lingen MW, Salgia R, Hirsch FR, Dziadziuszko R, Ballmer-Hofer K, et al. Novel functional germline variants in the VEGF receptor 2 gene and their effect on gene expression and microvessel density in lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5257-67. PMID 21712447 DOI: 10.1158/1078-0432.Ccr-11-0379 |
0.359 |
|
| 2011 |
Liu J, Kuo WL, Seiwert TY, Lingen M, Ciaccio MF, Jones RB, Rosner MR, Cohen EE. Effect of complementary pathway blockade on efficacy of combination enzastaurin and rapamycin. Head & Neck. 33: 1774-82. PMID 21438065 DOI: 10.1002/Hed.21701 |
0.352 |
|
| 2011 |
Leeman-Neill RJ, Seethala RR, Singh SV, Freilino ML, Bednash JS, Thomas SM, Panahandeh MC, Gooding WE, Joyce SC, Lingen MW, Neill DB, Grandis JR. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. Cancer Prevention Research (Philadelphia, Pa.). 4: 230-7. PMID 21163936 DOI: 10.1158/1940-6207.Capr-10-0249 |
0.385 |
|
| 2011 |
Glubb DM, Cerri E, Giese A, Zhang W, Mirza O, Thompson E, Jassem J, Rzyman W, Chen P, Das S, Lingen M, Salgia R, Hirsch FR, Dziadziuszko R, Ballmer-Hofer K, et al. Abstract 5136: Discovery of novel functional germline variations in the vascular endothelial growth factor receptor 2 gene (KDR) and their effect on gene expression and microvessel density in lung cancer Cancer Research. 71: 5136-5136. DOI: 10.1158/1538-7445.Am2011-5136 |
0.425 |
|
| 2010 |
Zhou G, Hasina R, Wroblewski K, Mankame TP, Doçi CL, Lingen MW. Dual inhibition of vascular endothelial growth factor receptor and epidermal growth factor receptor is an effective chemopreventive strategy in the mouse 4-NQO model of oral carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 3: 1493-502. PMID 20978113 DOI: 10.1158/1940-6207.Capr-10-0135 |
0.735 |
|
| 2010 |
Zhou G, Doçi CL, Lingen MW. Identification and functional analysis of NOL7 nuclear and nucleolar localization signals. Bmc Cell Biology. 11: 74. PMID 20875127 DOI: 10.1186/1471-2121-11-74 |
0.745 |
|
| 2010 |
Lingen MW. Screening for oral premalignancy and cancer: what platform and which biomarkers? Cancer Prevention Research (Philadelphia, Pa.). 3: 1056-9. PMID 20798207 DOI: 10.1158/1940-6207.Capr-10-0173 |
0.343 |
|
| 2010 |
Cohen EE, Haraf DJ, Kunnavakkam R, Stenson KM, Blair EA, Brockstein B, Lester EP, Salama JK, Dekker A, Williams R, Witt ME, Grushko TA, Dignam JJ, Lingen MW, Olopade OI, et al. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3336-43. PMID 20498391 DOI: 10.1200/Jco.2009.27.0397 |
0.327 |
|
| 2010 |
Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW, Patton LL, Perkins D, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. Journal of the American Dental Association (1939). 141: 509-20. PMID 20436098 DOI: 10.14219/Jada.Archive.2010.0223 |
0.319 |
|
| 2010 |
Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, Li J, Hasina R, Cheng C, Lingen MW, Gerstein MB, Weichselbaum RR, Xing HR, Lussier YA. Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis. Plos Computational Biology. 6: e1000730. PMID 20369013 DOI: 10.1371/Journal.Pcbi.1000730 |
0.375 |
|
| 2010 |
Lingen MW. Pragmatics versus contrarians: how does one resolve their differences with respect to oral cancer screening? Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 109: 325-6. PMID 20219595 DOI: 10.1016/J.Tripleo.2009.12.022 |
0.302 |
|
| 2010 |
Rothenberg SM, Mohapatra G, Rivera MN, Winokur D, Greninger P, Nitta M, Sadow PM, Sooriyakumar G, Brannigan BW, Ulman MJ, Perera RM, Wang R, Tam A, Ma XJ, Erlander M, ... ... Lingen MW, et al. A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Research. 70: 2158-64. PMID 20215515 DOI: 10.1158/0008-5472.Can-09-3458 |
0.369 |
|
| 2010 |
Mankame TP, Zhou G, Lingen MW. Identification and characterization of the human NOL7 gene promoter. Gene. 456: 36-44. PMID 20206243 DOI: 10.1016/J.Gene.2010.02.008 |
0.765 |
|
| 2010 |
Zhang Z, Neiva KG, Lingen MW, Ellis LM, Nör JE. VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2. Cell Death and Differentiation. 17: 499-512. PMID 19834490 DOI: 10.1038/Cdd.2009.152 |
0.357 |
|
| 2010 |
Lingen MW, Zhou G, Doci C. Abstract 3062: Identification and functional analysis of NOL7 tumor suppressor gene nuclear and nucleolar localization signals Cancer Research. 70: 3062-3062. DOI: 10.1158/1538-7445.Am10-3062 |
0.728 |
|
| 2010 |
Xing RH, Wu Y, Zhang Q, Huang Y, Shen J, Fan H, Li J, Xiao H, Lee Y, Weichselbaum R, Lingen M, Lussier YA. Abstract 1546: Effective co-targeting of tumor and tumor stroma for head and neck cancer treatment: making the right combination Cancer Research. 70: 1546-1546. DOI: 10.1158/1538-7445.Am10-1546 |
0.426 |
|
| 2009 |
Doebele RC, Schulze-Hoepfner FT, Hong J, Chlenski A, Zeitlin BD, Goel K, Gomes S, Liu Y, Abe MK, Nor JE, Lingen MW, Rosner MR. A novel interplay between Epac/Rap1 and mitogen-activated protein kinase kinase 5/extracellular signal-regulated kinase 5 (MEK5/ERK5) regulates thrombospondin to control angiogenesis. Blood. 114: 4592-600. PMID 19710505 DOI: 10.1182/Blood-2009-04-217042 |
0.35 |
|
| 2009 |
Hasina R, Martin LE, Kasza K, Jones CL, Jalil A, Lingen MW. ABT-510 is an effective chemopreventive agent in the mouse 4-nitroquinoline 1-oxide model of oral carcinogenesis. Cancer Prevention Research (Philadelphia, Pa.). 2: 385-93. PMID 19336725 DOI: 10.1158/1940-6207.Capr-08-0211 |
0.403 |
|
| 2009 |
Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, El Dinali M, Yala S, Kanteti R, Cohen EE, Lingen MW, Martin L, Krishnaswamy S, Klein-Szanto A, Christensen JG, Vokes EE, et al. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Research. 69: 3021-31. PMID 19318576 DOI: 10.1158/0008-5472.Can-08-2881 |
0.446 |
|
| 2009 |
Cohen EE, Zhu H, Lingen MW, Martin LE, Kuo WL, Choi EA, Kocherginsky M, Parker JS, Chung CH, Rosner MR. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Research. 69: 65-74. PMID 19117988 DOI: 10.1158/0008-5472.Can-08-0377 |
0.384 |
|
| 2008 |
Hasina R, Whipple ME, Martin LE, Kuo WP, Ohno-Machado L, Lingen MW. Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 342-53. PMID 18283272 DOI: 10.1038/Labinvest.2008.6 |
0.429 |
|
| 2008 |
Radhakrishnan R, Solomon M, Satyamoorthy K, Martin LE, Lingen MW. Tissue microarray - a high-throughput molecular analysis in head and neck cancer. Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 37: 166-76. PMID 18251941 DOI: 10.1111/J.1600-0714.2007.00606.X |
0.327 |
|
| 2008 |
Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, Loganathan S, Kanteti R, Reichman T, Nallasura V, Schwartz S, Faoro L, Wang YC, Girard L, Tretiakova MS, ... ... Lingen MW, et al. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Research. 68: 132-42. PMID 18172305 DOI: 10.1158/0008-5472.Can-07-1998 |
0.37 |
|
| 2008 |
Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncology. 44: 10-22. PMID 17825602 DOI: 10.1016/J.Oraloncology.2007.06.011 |
0.326 |
|
| 2007 |
Kaneko T, Zhang Z, Mantellini MG, Karl E, Zeitlin B, Verhaegen M, Soengas MS, Lingen M, Strieter RM, Nunez G, Nör JE. Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Research. 67: 9685-93. PMID 17942898 DOI: 10.1158/0008-5472.Can-07-1497 |
0.431 |
|
| 2007 |
Hong J, Doebele RC, Lingen MW, Quilliam LA, Tang WJ, Rosner MR. Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. The Journal of Biological Chemistry. 282: 19781-7. PMID 17491018 DOI: 10.1074/Jbc.M700128200 |
0.328 |
|
| 2007 |
Seiwert T, Janamanchi V, Klein-Szanto A, Jagadeeswaran R, Martin L, Lingen M, Cohen E, Ridge J, Vokes E, Salgia R. The Receptor Tyrosine Kinase c-MET as a Novel Therapeutic Target in Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 69: S137. DOI: 10.1016/J.Ijrobp.2007.06.004 |
0.309 |
|
| 2006 |
Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C, Martin LE, Rosner MR. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Research. 66: 6296-303. PMID 16778206 DOI: 10.1158/0008-5472.Can-05-3139 |
0.388 |
|
| 2006 |
Connell PP, Jayathilaka K, Haraf DJ, Weichselbaum RR, Vokes EE, Lingen MW. Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. International Journal of Oncology. 28: 1113-9. PMID 16596227 DOI: 10.3892/Ijo.28.5.1113 |
0.417 |
|
| 2006 |
Antico G, Lingen MW, Sassano A, Melby J, Welch RW, Fiore S, Pilon AL, Miele L. Recombinant human uteroglobin/CC10 inhibits the adhesion and migration of primary human endothelial cells via specific and saturable binding to fibronectin. Journal of Cellular Physiology. 207: 553-61. PMID 16453303 DOI: 10.1002/Jcp.20604 |
0.322 |
|
| 2006 |
Hasina R, Pontier AL, Fekete MJ, Martin LE, Qi XM, Brigaudeau C, Pramanik R, Cline EI, Coignet LJ, Lingen MW. NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype Oncogene. 25: 588-598. PMID 16205646 DOI: 10.1038/Sj.Onc.1209070 |
0.438 |
|
| 2006 |
Seiwert TY, Klein-Szanto AJ, Jagadeeswaran R, Tretiakova M, Martin L, Lingen MW, Cohen EE, Ridge JA, Vokes EE, Salgia R. S115 The Receptor Tyrosine Kinase c-MET Is Mutated in Head and Neck Cancer and Is a Promising Novel Target Archives of Otolaryngology–Head & Neck Surgery. 132: 864. DOI: 10.1001/Archotol.132.8.864-B |
0.383 |
|
| 2005 |
Cohen EE, Lingen MW, Martin LE, Harris PL, Brannigan BW, Haserlat SM, Okimoto RA, Sgroi DC, Dahiya S, Muir B, Clark JR, Rocco JW, Vokes EE, Haber DA, Bell DW. Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 8105-8. PMID 16299242 DOI: 10.1158/1078-0432.Ccr-05-0926 |
0.323 |
|
| 2004 |
Ma PC, Tretiakova MS, Jagadeeswaran R, Jagadeesh S, Nallasura V, Kindler HL, Lingen M, Vokes EE, Husain A, Salgia R. Role of c-MET in lung cancer, malignant mesothelioma, and head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 9539. PMID 28016812 DOI: 10.1200/Jco.2004.22.14_Suppl.9539 |
0.345 |
|
| 2004 |
Hasina R, Lingen MW. Head and neck cancer: the pursuit of molecular diagnostic markers. Seminars in Oncology. 31: 718-25. PMID 15599849 DOI: 10.1053/J.Seminoncol.2004.09.012 |
0.352 |
|
| 2004 |
Petro BJ, Tan RC, Tyner AL, Lingen MW, Watanabe K. Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium Oral Oncology. 40: 1040-1047. PMID 15509496 DOI: 10.1016/J.Oraloncology.2004.05.010 |
0.372 |
|
| 2004 |
Nickoloff BJ, Lingen MW, Chang BD, Shen M, Swift M, Curry J, Bacon P, Bodner B, Roninson IB. Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Research. 64: 2956-61. PMID 15126325 DOI: 10.1158/0008-5472.Can-03-2388 |
0.415 |
|
| 2004 |
Cohen EE, Lingen MW, Vokes EE. The expanding role of systemic therapy in head and neck cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1743-52. PMID 15117998 DOI: 10.1200/Jco.2004.06.147 |
0.307 |
|
| 2004 |
Hasina R, Kuo W, Ohno-Machado L, Lingen M. Intertumoral angiogenic heterogeneity: biologic and therapeutic implications Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 98: 203. DOI: 10.1016/J.Tripleo.2004.06.039 |
0.397 |
|
| 2003 |
Hasina R, Hulett K, Bicciato S, Di Bello C, Petruzzelli GJ, Lingen MW. Plasminogen activator inhibitor-2: a molecular biomarker for head and neck cancer progression. Cancer Research. 63: 555-9. PMID 12566295 |
0.311 |
|
| 2003 |
King R, Herr B, Fekete M, Lingen M. Use of proteomics for identifying molecular markers of oral cancer Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology. 96: 301. DOI: 10.1016/S1079-2104(03)00389-5 |
0.311 |
|
| 2002 |
Cline EI, Bicciato S, DiBello C, Lingen MW. Prediction of in vivo synergistic activity of antiangiogenic compounds by gene expression profiling. Cancer Research. 62: 7143-8. PMID 12499246 |
0.311 |
|
| 2002 |
Liss C, Fekete MJ, Hasina R, Lingen MW. Retinoic acid modulates the ability of macrophages to participate in the induction of the angiogenic phenotype in head and neck squamous cell carcinoma. International Journal of Cancer. 100: 283-9. PMID 12115542 DOI: 10.1002/Ijc.10507 |
0.382 |
|
| 2002 |
Curry JL, Petruzzelli GJ, McClatchey KD, Lingen MW. Synchronous benign and malignant salivary gland tumors in ipsilateral glands: a report of two cases and a review of literature. Head & Neck. 24: 301-6. PMID 11891964 DOI: 10.1002/Hed.10048 |
0.32 |
|
| 2001 |
Hasina R, Lingen MW. Angiogenesis in oral cancer Journal of Dental Education. 65: 1282-1290. PMID 11765876 DOI: 10.1002/J.0022-0337.2001.65.11.Tb03489.X |
0.437 |
|
| 2001 |
Liss C, Fekete MJ, Hasina R, Lam CD, Lingen MW. Paracrine angiogenic loop between head-and-neck squamous-cell carcinomas and macrophages International Journal of Cancer. 93: 781-785. PMID 11519037 DOI: 10.1002/Ijc.1407 |
0.384 |
|
| 2001 |
Kini AR, Peterson LA, Tallman MS, Lingen MW. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood. 97: 3919-24. PMID 11389035 DOI: 10.1182/Blood.V97.12.3919 |
0.324 |
|
| 2001 |
Lingen M, Sturgis EM, Kies MS. Squamous cell carcinoma of the head and neck in nonsmokers: clinical and biologic characteristics and implications for management. Current Opinion in Oncology. 13: 176-82. PMID 11307061 DOI: 10.1097/00001622-200105000-00008 |
0.334 |
|
| 2000 |
Lingen MW, Emami B, Clark JI. New therapeutic strategies for the treatment and prevention of head and neck cancer Expert Opinion On Investigational Drugs. 9: 2855-2872. PMID 11093357 DOI: 10.1517/13543784.9.12.2855 |
0.331 |
|
| 2000 |
Lingen MW, Chang KW, McMurray SJ, Solt DB, Kies MS, Mittal BB, Haines GK, Pelzer HJ. Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9 Head and Neck. 22: 328-335. PMID 10862014 DOI: 10.1002/1097-0347(200007)22:4<328::Aid-Hed3>3.0.Co;2-R |
0.39 |
|
| 1999 |
Lingen MW. Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents Critical Reviews in Oral Biology and Medicine. 10: 153-164. PMID 10759419 DOI: 10.1177/10454411990100020301 |
0.393 |
|
| 1999 |
Bentz BG, Pelzer HJ, Haines GK, Hanson DG, Lingen MW, Radosevich JA. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck Annals of Otology, Rhinology and Laryngology. 108: 781-787. PMID 10453787 DOI: 10.1177/000348949910800812 |
0.351 |
|
| 1999 |
Dardick I, Birek C, Lingen MW, Rowe PE. Differentiation and the cytomorphology of salivary gland tumors with specific reference to oncocytic metaplasia Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 88: 691-701. DOI: 10.1016/S1079-2104(99)70012-0 |
0.37 |
|
| 1997 |
Lingen MW, DiPietro LA, Solt DB, Bouck NP, Polverini PJ. The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFbeta-1 and is unaffected by ras activation. Carcinogenesis. 18: 329-38. PMID 9054625 DOI: 10.1093/Carcin/18.2.329 |
0.3 |
|
| 1996 |
Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, Molteni A, Polverini PJ, Bouck NP. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats Journal of Clinical Investigation. 98: 671-679. PMID 8698858 DOI: 10.1172/Jci118838 |
0.312 |
|
| 1996 |
Lingen MW, Polverini PJ, Bouck NP. Retinoic acid and interferon-alpha act synergistically to inhibit tumor angiogenesis Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 82: 212. DOI: 10.1016/S1079-2104(96)80257-5 |
0.357 |
|
| 1996 |
Pelzer HJ, Lingen M, Kies M, Mittal B. 10:36 AM: High Incidence of p53 Overexpression in Squamous Cell Carcinoma of the Tongue in Young Patients with No Known Tisk Factors Otolaryngology–Head and Neck Surgery. 115: P108-P109. DOI: 10.1016/S0194-5998(96)80716-9 |
0.331 |
|
| Show low-probability matches. |